COMMENTARY

New Prescription Drug Benefit: The Role of the Oncologist

Jointly authored by officers of the American Society of Clinical Oncology and The CEO Roundtable On Cancer
The Oncologist 2005; 10: 561-562 ; doi:10.1634/theoncologist.10-8-561
[Abstract] [Full Text] [PDF]  

Help Your Patients Become Aware of the New Medicare Prescription Drug Plans

Mark McClellan
The Oncologist 2005; 10: 563-564 ; doi:10.1634/theoncologist.10-8-563
[Full Text] [PDF]  

Development of Farnesyl Transferase Inhibitors: A Review

Natalie M.G.M. Appels, Jos H. Beijnen, Jan H.M. Schellens
The Oncologist 2005; 10: 565-578 ; doi:10.1634/theoncologist.10-8-565
[Abstract] [Full Text] [PDF]  

Current Knowledge and Future Directions of the Selective Epidermal Growth Factor Receptor Inhibitors Erlotinib (Tarceva^®) and Gefitinib (Iressa^®)

Wandena S. Siegel-Lakhai, Jos H. Beijnen, Jan H.M. Schellens
The Oncologist 2005; 10: 579-589 ; doi:10.1634/theoncologist.10-8-579
[Abstract] [Full Text] [PDF]  

Targeted Therapies for Esophageal Cancer

William P. Tew, David P. Kelsen, David H. Ilson
The Oncologist 2005; 10: 590-601 ; doi:10.1634/theoncologist.10-8-590
[Abstract] [Full Text] [PDF]  

Clinical Pharmacology Issues Relevant to the Dosing and Toxicity of Chemotherapy Drugs in the Elderly

Tarun Wasil, Stuart M. Lichtman
The Oncologist 2005; 10: 602-612 ; doi:10.1634/theoncologist.10-8-602
[Abstract] [Full Text] [PDF] [Supplemental Data]  

Fertility-Sparing Options for Patients with Gynecologic Malignancies

Mario M. Leitao, Jr, Dennis S. Chi
The Oncologist 2005; 10: 613-622 ; doi:10.1634/theoncologist.10-8-613
[Abstract] [Full Text] [PDF]  

Adjuvant Radiotherapy in Endometrial Carcinoma

David T. Shaeffer, Marcus E. Randall
The Oncologist 2005; 10: 623-631 ; doi:10.1634/theoncologist.10-8-623
[Abstract] [Full Text] [PDF]  

Lymphomas and Chylous Ascites: Review of the Literature

Tony Almakdisi, Samuel Massoud, George Makdisi
The Oncologist 2005; 10: 632-635 ; doi:10.1634/theoncologist.10-8-632
[Abstract] [Full Text] [PDF]  

Informed Consent for Medical Treatment and Research: A Review

Marcela G. del Carmen, Steven Joffe
The Oncologist 2005; 10: 636-641 ; doi:10.1634/theoncologist.10-8-636
[Abstract] [Full Text] [PDF]  

Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and Darbepoetin Alfa (200 µg Every 2 Weeks) in Anemic Patients with Cancer Receiving Chemotherapy

Roger Waltzman, Christopher Croot, Glen R. Justice, Mark R. Fesen, Veena Charu, Denise Williams
The Oncologist 2005; 10: 642-650 ; doi:10.1634/theoncologist.10-8-642
[Abstract] [Full Text] [PDF]  

Laughter: The Best Medicine?

Richard T. Penson, Rosamund A. Partridge, Pandora Rudd, Michael V. Seiden, Jill E. Nelson, Bruce A. Chabner, Thomas J. Lynch, Jr.
The Oncologist 2005; 10: 651-660 ; doi:10.1634/theoncologist.10-8-651
[Abstract] [Full Text] [PDF]  

Katrina’s Lessons: Out of the Worst Come Some of the Best

Jayne Gurtler
The Oncologist 2005; 10: 661-662 ; doi:10.1634/theoncologist.10-8-661
[Full Text] [PDF]  

Terrorism and Cancer... Four Years After 9/11

Gregory A. Curt
The Oncologist 2005; 10: 663 ; doi:10.1634/theoncologist.10-8-663
[Full Text] [PDF]  

Modern Minutemen

Joseph J. Fins
The Oncologist 2005; 10: 664 ; doi:10.1634/theoncologist.10-8-664
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.